ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
9,119 announcements with these filters
Q2 FY27 revenue INR 6,965mn (+19% YoY); H1 INR 12,411mn (+15%). H1 PAT INR 665mn (+9%); EBITDA margin 9.7% (vs 10.4%). Domestic-led growth; margin recovery expected to be gradual.
H1 FY27 revenue ₹273.3 cr (+12.6%), PAT ₹10.0 cr (−52.3%), EBITDA margin 11.6% (−343 bps). Q2 revenue +2.6%, PAT ₹4.8 cr (−65.7%). Exports growing; domestic declining.
Q2 FY27 revenue ₹166.2 cr (+72% YoY), EBITDA ₹19.2 cr (11.6% margin), PAT ₹9.2 cr (5.5% margin). Pivoting into BESS via Zenwatt; Africa export push.
H1 FY27 revenue ₹9,284.5 Lacs (+16.99%), EBITDA ₹1,119.3 Lacs (+14.23%), PAT ₹806.3 Lacs (+10.17%). Strategy centres on retail and experience-centre expansion plus B2B growth.
Revenue ₹5,542 Cr, up 16.6% YoY on a weak base. Management gave no margin outlook amid broad input inflation and deflected gross-margin and per-kg cost questions.
Q2 FY27 AUM rose 25% YoY to ₹3,500 Cr, and NII jumped on a one-time DA upfront fee. Forward flow fell to 0.50% and GNPA is 4.61%. Net profit was not stated.
Q2 bookings ₹906 Cr (2.1x YoY); H1 revenue ₹475 Cr (+96%). FY27 bookings guidance raised to 70–75%, but margin guidance kept at 22–25% despite claimed beats.
H1 FY27 revenue ₹91.33 Cr (+16.6%), PAT ₹0.33 Cr (vs ₹0.13 Cr), EBITDA ₹2.06 Cr (-5.5%). EBO-led shift, store expansion to 84.
Q2 FY27 revenue ₹514 Cr (-16% YoY), EBITDA ₹25 Cr at 4.8% margin, net profit ₹6 Cr. Record ₹5,001 Cr order book, up 48% YoY.
Q2FY27 total income Rs290 Cr (-10.8%), EBITDA Rs15 Cr, PAT Rs1 Cr turnaround on sugar realisation up 13%, despite lower volumes. H1 PAT -Rs11 Cr.
Q2 consolidated revenue ₹105.61 Cr (+102%), PAT ₹17.18 Cr (+84%). EBITDA margin recovered to 23.9%, still below the 25-30% guided band. FY27 revenue reiterated at ₹380-400 Cr.
Q2FY27 consolidated total income ₹821 Cr (+11% YoY), EBITDA ₹202 Cr (+41%, 25% margin), PAT ₹65 Cr (+14%). Controlling stake in Bliss GVS Pharma acquired 28 Sep 2026.
Record standalone revenue ₹2,526 Cr (+30% YoY), but consolidated EBITDA up only 9%. US loss-making, Europe at 3% margin; H2 recovery hinges on cost pass-through.
Revenue ₹1,592 Cr (+104% YoY, mostly TrueBridge consolidation) and EBITDA ₹442 Cr (~28%). Legacy IKS grew ~13% in USD. TrueBridge is flat for FY27, and management gives no growth guidance.
Q2 standalone revenue rose 38% and PAT 31%, helped by marketing fees. FY27 standalone revenue target reiterated despite slow H1 awards.
Management claims record profitability and AUM up ~95% YoY, but analyst-cited QoQ AUM growth was ~3%. Collection efficiency fell from ~98% to ~90%, with NPAs rising.
Q2 FY27 revenue Rs 852.4 Cr (+36% YoY), but EBITDA margin fell to 0.7% and PAT was -Rs 26.3 Cr on air-freight and input-cost overruns.
Q2 revenue +9.5% and PAT +30.4%, but H1 growth is price-aided and EBITDA margin slipped to 11.5%. Management hedges on H2 recovery and margins amid a steel cost surge; spares fell 4.7% in Q2.
Headline strong: consolidated PAT +57.7% to ₹45.3 Cr, EBITDA +27.5% to ₹100 Cr. Management sidestepped separator economics, timelines and Noida weakness; no quantified guidance.
Q2 FY27 volume grew ~15% and EBITDA margin recovered to 23% from 14.4% in Q1 after price hikes. Management guides FY27 revenue of ₹375-400 Cr. Q2 net profit was not disclosed on the call.
Q2 FY27 missed: consolidated revenue +8% YoY to ₹875 Cr, EBITDA down 19% to ₹87 Cr at 9.9% margin. Management admits Q2 was unsatisfactory and trimmed FY27 revenue guidance to 16-18% from 18-20%.
Q2 FY27 standalone revenue INR45,752 cr (+17%) and PAT INR5,320 cr (+14%); group H1 PAT +26%. NGEL H1 revenue +58% at 89% EBITDA margin. RE capacity addition slipping on transmission delays; thermal pipeline expanding.
H1 FY27 revenue INR12,824cr (+25.97%), PAT INR2,589cr (+14.80%), order book INR68,717cr. Management held guidance: 15%+ growth, ~28% EBITDA margin.
Revenue +60% YoY to ₹363.8 Cr, but margin fell to 20.6% and PAT dropped 20%. Management blames accounting timing and input costs, reiterates ₹2,000 Cr FY27 guidance despite rising debt and negative OCF.
Q2 FY27 revenue ₹209 Cr (+27% YoY), EBITDA margin 13.4%, PAT ₹13 Cr (+18%). Management hedges on geopolitics, block-2 timing and depreciation; segment figures are thin.
Q2 FY27 One Sudarshan revenue ₹2,743 Cr (+14.9% YoY), business EBITDA ₹239 Cr (8.7% margin, +4.7pp). Integration progressing; VP4 sale completed 2 Nov 2026.
H1 FY27 revenue ₹186.21 Cr (+89%) and PAT ₹84.27 Cr (+267%), driven by a large dredging win. Management calls Q2 seasonally soft, so H2 must deliver on pending tenders.
Strong Q2 FY27: revenue +42% YoY, PAT +48%, order book ₹2,000 Cr (+93% YoY). EBITDA margin slipped QoQ on commodity costs, and FY28 growth is guided lower at 10-15%. Management deflected on volume/price split and capacity utilisation.
Q2 FY27 revenue ₹1,083 Cr, +55% YoY, largely price pass-through; specialty margins fell on hedge fixed costs. Management upbeat, but evasive on spreads; working capital elevated.
Q2 revenue rose only 1.6% on a weak agro monsoon, but EBITDA margin widened to 13.3% on mix and procurement. Management guided subdued agro demand and H2 cost pressure, with no numeric outlook.